Le Lézard
Classified in: Health, Science and technology
Subject: OBI

Ethnobotanist and Herbal Medicine Advocate Jim Duke Dies at 88


AUSTIN, Texas, Dec. 11, 2017 /PRNewswire-USNewswire/ -- Jim Duke, PhD, an esteemed ethnobotanist, author, and a co-founder of the American Botanical Council (ABC), died at his home last evening. He was 88 and had been in declining health.

American Botanical Council Now in Our 30th Year

"He was a brilliant, dedicated, funny, and humble man, who earned the admiration, respect, and love of thousands of scientists and herbal enthusiasts," said Mark Blumenthal, ABC's founder and executive director. "Jim's huge body of work, love of plants and people, sense of humor, and generosity of spirit are positive examples for all of us."

Duke authored hundreds of articles and an estimated three dozen books, both popular and technical. He compiled botanical data from all types of sources for his "Father Nature's Farmacy" database, and was a humble botanist who preferred to walk barefoot in his extensive medicinal plant garden, or, when possible, the Amazonian rainforest.

Born in Birmingham, Alabama, on April 4, 1929, Duke studied botany at the University of North Carolina, where he received his undergraduate and doctoral degrees in 1955 and 1961, respectively. Postgraduate work took him to Washington University and the Missouri Botanical Garden in St. Louis. It was there where he developed what was, as he put it, "my overriding interest: neotropical ethnobotany."

Early in Duke's career with Missouri Botanical Garden, his work took him to Panama, where he penned painstaking technical descriptions of plants in 11 plants families for the Flora of Panama project published in the Annals of the Missouri Botanical Garden. He also studied the ethnobotany of the Choco and Cuna native groups, which culminated in his first book: Isthmian Ethnobotanical Dictionary, a 96-page handbook describing medicinal plants of the Central American isthmus.

In 1963, Jim Duke took a position with the USDA in Beltsville, Maryland. From 1965 to 1971, he worked on ecological and ethnological research in Panama and Colombia for Battelle Memorial Institute. Duke returned to USDA in 1971, where he worked on crop diversification and created a database called the "Crop Diversification Matrix" with extensive biological, ecological, and economic data on thousands of cultivated crops.

His interest in medicinal plants never waned. In 1977, he became chief of the Medicinal Plant Laboratory at USDA's Agricultural Research Service in Beltsville, and then chief of USDA's Economic Botany Laboratory. At the time, USDA was under contract with the National Cancer Institute (NCI) to collect plant materials from all over the world for screening for anti-cancer activity. After the program ended in 1981, Jim Duke continued his work at the Germplasm Resources Laboratory. Duke served on the board of the Amazon Center for Environmental Education and Research (ACEER) in the early 1990s, and the nonprofit created a fund in his honor to support its educational programs in 2007. Duke also received the ACEER Legacy Award in 2013.

Duke established the Green Farmacy Garden in Fulton, Maryland, in 1997 as a teaching garden with approximately 300 species of medicinal plants. For several years, Duke hosted the AHPA-ABC HerbWalk as a part of Natural Products Expo East.

Duke retired from USDA in 1995, but retirement was in name only. Shortly thereafter, The New York Times published a profile on Duke. (HerbalGram published a bio on Duke in issue 77.)

"His impact and inspiration for the last three generations of all aspects of the herbal community cannot be overstated," said Steven Foster, an author, photographer, and collaborator with Duke on multiple books. "He was a renaissance man in the broadest sense."

Duke is survived by his wife Peggy, daughter Cissy, and son John.

About the American Botanical Council

Media contact: Tanya Garduño, (512) 926-4900 Ext:129, [email protected]

SOURCE American Botanical Council


These press releases may also interest you

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...



News published on and distributed by: